Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukapheresis in multiple sclerosis.

W A Sibley, D W Heustis, M M Griffith

    Neurologia, Neurocirugia, Psiquiatria
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Leukapheresis safely collects lymphocytes from multiple sclerosis (MS) patients for research. This procedure is safe for MS patients and does not worsen their condition, offering a valuable tool for studying MS pathogenesis.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Bordetella holmesii in children suspected of pertussis in Argentina.

    Epidemiology and infection·2012
    Same author

    Concentration-dependent energy-transfer processes in Er(3+)-and Tm(3+)-doped heavy-metal fluoride glass.

    Optics letters·2009
    Same author

    Stimulated emission and tunable gain from Rh(2+) ions in RbCaF(3) crystals.

    Optics letters·2009
    Same author

    Spotlight series: pivotal trials through today's knowledge--adrenocorticotrophic hormone.

    International MS journal·2009
    Same author

    Corticosteroids or ACTH for acute exacerbations in multiple sclerosis.

    The Cochrane database of systematic reviews·2000
    Same author

    The relationship of MS to physical trauma and psychological stress [RETIRED]: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.

    Neurology·1999
    Same journal

    [Hospitalized psychiatric population in the Mexican Institute of the Social Security, 1971-1976].

    Neurologia, neurocirugia, psiquiatria·1978
    Same journal

    [Child psychiatry and social security].

    Neurologia, neurocirugia, psiquiatria·1978
    Same journal

    [Thermodynamics and electrophysiology of the nervous system].

    Neurologia, neurocirugia, psiquiatria·1978
    Same journal

    [Television and the viewer: an uneven fight].

    Neurologia, neurocirugia, psiquiatria·1978
    Same journal

    [Levels of consciousness].

    Neurologia, neurocirugia, psiquiatria·1978
    Same journal

    [Theories of consciousness. Certain neurophysiologic aspects of consciousness. Experimental findings and speculation].

    Neurologia, neurocirugia, psiquiatria·1978
    See all related articles

    Area of Science:

    • Neurology
    • Immunology
    • Hematology

    Background:

    • Lack of a suitable animal model for multiple sclerosis (MS) necessitates direct patient tissue study.
    • Leukapheresis offers a method to obtain patient-derived leukocytes for research.

    Purpose of the Study:

    • To evaluate the safety and efficacy of leukapheresis in multiple sclerosis (MS) patients.
    • To assess leukapheresis as a potential research tool for studying MS pathogenesis.

    Main Methods:

    • Leukapheresis procedure using ACD-B anticoagulant to process 3500 ml of blood.
    • Collected an average of 6.7 billion lymphocytes per procedure.
    • Monitored blood counts and differential leukocyte counts post-procedure.

    Main Results:

    Related Experiment Videos

    • Leukapheresis was performed safely in four MS patients across all disease stages.
    • No significant adverse changes in circulating blood or differential leukocyte counts were observed.
    • Platelet counts showed a slight decrease post-procedure.

    Conclusions:

    • Leukapheresis is a safe procedure for MS patients and does not negatively impact the illness course.
    • Leukapheresis is currently best utilized as a research tool for MS pathogenesis studies.
    • Potential future therapeutic applications may arise if lymphocyte cytolytic function in the CNS is confirmed.